Dr. Jeanmarie Guenot’s Efforts to Eradicate Deadly Diseases by Developing Innovative Drugs


Jeanmarie Guenot  has the privilege of working with firms of all stages, ranging from pharmaceutical R&D, business development, corporate & commercial development, and venture capital. Guenot has unsurpassed expertise and talent in creating and recreating companies. Today, she is the head of Amphivena Therapeutics, Inc., a prominent firm that is creating unique bifunctional antibody medicines for the management of hematologic malignancies. In 2013, Amphivena Therapeutics conducted a Series A funding headed by MPM Capital and managed to raise a record $14 million.


Contributions to the expansion of pharmaceutical sector


Jeanmarie Guenot launched her professional business career at the renowned Atlas Venture, where she oversaw venture capital investments and established life science firms. She commenced her career as a researcher and scientist after joining the Hoffmann-La Roche’s Preclinical R&D as the principal scientist. Guenot led a team of researchers in discovering and creating medications for autoimmune diseases, metabolic diseases, oncology, and inflammation.


Jeanmarie Guenot offered business advisory services to Hoffmann-La Roche in Shanghai and Basel. At a particular time in her career, Guenot was the VP of PDL Alliance Management in charge of managing commercial product portfolios. She oversaw and led the negotiations of the Biogen Idec-PDL 50:50 co-design and co-commercialization partnership that comprised of three Phase 2 drugs for the treatment of autoimmune and cancer. Guenot has a diversified portfolio consisting of extensive experience in project and partnership management, especially in the specialties of cardiovascular diseases, neurology, oncology, ophthalmic disease.




Guenot is a creative individual behind several well-performing medications and state-of-the-art equipment. She incepted, developed, and operated SKS Ocular, an innovative ophthalmic company incubator that concentrates on dry AMS, macular degeneration, reliable ocular drug delivery techniques, and ocular inflammation.





Guenot is a trained scientist in the fields of medicinal and physical chemistry. She has specialized in semi-empirical as well as quantum mechanical techniques for protein structure prediction, drug development, molecular dynamics, and refinement of NMR and X-ray. Guenot studied at the University of California and obtained her Ph.D. She attained her MBA from the celebrated University of Pennsylvania’s The Wharton School.

Arizona’s Jason Hope is Focused on the Future

Based in Scottsdale, AZ, Jason Hope is a well-known entrepreneur, futurist and philanthropist. While his own career has been focused on mobile application, software and gaming development, his philanthropic interests have been widespread through humanitarian efforts, education and technology.

Hope is most known for his philanthropic interest in biotechnology development and research, having famously donated half a million dollars to the SENS Foundation, which works to develop rejuvenation technologies and studies age-related diseases. Hope strongly supports the mission of SENS which is to prevent age-related diseases rather than treating their symptoms. This generation contribution was used to establish a research laboratory dedicated to the Foundations AGE-Breaker program. He has also given tirelessly to local educational organizations for the sciences and entities focused on the study of disease prevention and cure, notably stating that biotechnology is the future. “It’s about creating a longer, better quality of life,” quotes Hope on his website, urging others to consider supporting research efforts.

His true dedication to the future of scientific research is evidenced by his involvement with such organizations the Leukemia & Lymphoma Society’s Desert Mountain States Chapter, Family Health International and the TGen Foundation.

Hope supports organizations focused on providing children in the state with educational opportunities both inside and outside of the classroom, including the Arizona Science Center where he is a member of the Director’s Circle. Supporting countless local charities as well, Hope’s blog states that his goal is to see local Arizona communities thrive.

Always with a vision to toward the future and advancement of scientific discovery, Jason Hope also sponsors grants to fund the research of the next generation of innovators. Ranging in award amount of $500 to $5000, these grants offer high school seniors and college students the means to pursue and develop technology advances that would otherwise be impossible. Jason Hope uses his own success in technology development to guide young entrepreneurs through mentorship and to support them with investment opportunities.